Giuseppina Folesani

Dr. Giuseppina Folesani


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
Massimo CorradiMassimo Corradi
Massimo Corradi
GFGiuseppina Folesani
Giuseppina Folesani
RARoberta Andreoli
Roberta Andreoli
PMPaola Manini
Paola Manini
ABAlessandro Bodini
Alessandro Bodini
EBEugenio Baraldi
Eugenio Baraldi
Oxidative stress is implicated in the pathogenesis of asthma, and clinical studies show an imbalance in the level of oxidants to the level of antioxidants in subjects with asthma. Aldehydes and glutathione are examples of biomarkers of oxidant-induced damage and antioxidant status in asthma, respectively. In the study, we applied analytical techniques based on liquid chromatography for the assessment of aldehydes and glutathione in the exhaled breath condensate of children with asthma and in control subjects without asthma. Twelve subjects with asthma were evaluated at exacerbation and after 5 days of therapy with prednisone. At exacerbation, malondialdehyde levels were higher in patients with asthma (30.2 ± 2.4 nM) than in control subjects (19.4 ± 1.9 nM, p = 0.002) and were reduced after steroid therapy (18.5 ± 1.6 nM, p = 0.001). At exacerbation, glutathione levels were lower in subjects with asthma (5.96 ± 0.6 nM) than in control subjects (14.1 ± 0.8 nM, p < 0.0001) and were increased after the therapy (8.44 ± 1.2 nM, p = 0.04). Malondialdehyde and glutathione both in subjects with asthma and control subjects were negatively correlated (r = −0.5, p = 0.001). The study shows that aldehydes and glutathione are detectable in the exhaled breath condensate of children with asthma and healthy children and that their levels are modified during asthma exacerbation and after a 5-day course of therapy with oral prednisone.

1 August 2002 in Toxicology Letters
Verified
Journal Article
Closed access
Massimo CorradiMassimo Corradi
Massimo Corradi
RARossella Alinovi
Rossella Alinovi
Matteo GoldoniMatteo Goldoni
Matteo Goldoni
MVMaria Vittoria Vettori
Maria Vittoria Vettori
GFGiuseppina Folesani
Giuseppina Folesani
AMAntonio Mutti
Antonio Mutti

2 February 2005 in Allergy
Verified
Journal Article
Closed access
PDF file
SCS. Carraro
S. Carraro
GFGiuseppina Folesani
Giuseppina Folesani
Massimo CorradiMassimo Corradi
Massimo Corradi
SZS. Zanconato
S. Zanconato
BGB. Gaston
B. Gaston
EBEugenio Baraldi
Eugenio Baraldi

1 September 2006 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
GBGea Bonetto
Gea Bonetto
Massimo CorradiMassimo Corradi
Massimo Corradi
SCSilvia Carraro
Silvia Carraro
SZStefania Zanconato
Stefania Zanconato
RARossella Alinovi
Rossella Alinovi
EBEugenio Baraldi
Eugenio Baraldi
Rationale: Acute exposure to chlorine gas results in respiratory impairment, but few data are available on the pathobiology of the underlying lung damage. Objectives: To assess lung function and potential lung damage pathways in the acute phase and longitudinally over a 15-mo follow-up after acute chlorine exposure. Methods: Ten previously healthy children were accidentally exposed to chlorine gas at a swimming pool because of an erroneous servicing procedure. The fraction of nitric oxide in exhaled air (FeNO), exhaled breath condensate compounds, and serum Clara cell–specific protein CC16 were repeatedly measured. Main results: In the acute phase, all patients had respiratory distress (one child required mechanical ventilation) and reduced lung function (median and interquartile range: FVC, 51 [43–60]% predicted; FEV1, 51 [46–60]% predicted). This was accompanied by low FeNO (4.7 [3.9–7.9] ppb), high exhaled breath condensate leukotriene B4 (LTB4) levels (24.4 [22.5–24.9] pg/ml), and increased serum CC16 levels (mean ± SEM, 23.4 ± 2.5 μg/L). Lung function returned to normal in 15 d (FVC, 97% predicted [82–108], and FEV1, 92% predicted [77–102]). FeNO reached normal values after 2 mo (12.6 [11.4–15] ppb), whereas LTB4 levels were still increased (12 [9.3–17.1] pg/ml). Conclusion: Children acutely exposed to chlorine in a swimming pool presented a substantial lung function impairment associated with biochemical exhaled breath alterations, represented mainly by an increase in LTB4 and a reduction in FeNO. Although lung function and FeNO improved within a few weeks, the increased levels of exhaled LTB4 persisted for several months.

1 December 2006 in Toxicology Letters
Verified
Journal Article
Closed access
PMPaola Manini
Paola Manini
Giuseppe De PalmaGiuseppe De Palma
Giuseppe De Palma
RARoberta Andreoli
Roberta Andreoli
DPDiana Poli
Diana Poli
PMPaola Mozzoni
Paola Mozzoni
PAPietro Apostoli
Pietro Apostoli

15 January 2016 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
ANAntonio Nouvenne
Antonio Nouvenne
ATAndrea Ticinesi
Andrea Ticinesi
GFGiuseppina Folesani
Giuseppina Folesani
Nicoletta CerundoloNicoletta Cerundolo
Nicoletta Cerundolo
BPBeatrice Prati
Beatrice Prati
TMtiziana meschi
tiziana meschi
Serum procalcitonin and high-sensitivity C-reactive protein (hs-CRP) elevations have been associated with pneumonia in adults. Our aim was to establish their diagnostic usefulness in a cohort of hospitalized multimorbid patients ≥65 years old admitted to hospital with acute respiratory symptoms. With a retrospective cohort study design, all multimorbid patients ≥65 years-old with acute respiratory symptoms admitted to an internal medicine hospital ward in Italy from January to August 2013 were evaluated. Pneumonia diagnosis, comorbidities expressed through Cumulative Illness Rating Scale (CIRS), setting of living, length of stay, serum hs-CRP and procalcitonin at admission were collected for each patient. Data were analyzed with Mann-Whitney’s U test and multivariate Cox logistic regression analysis. A Receiver Operating Characteristic (ROC) curve was used to verify each biomarker’s association with pneumonia diagnosis. Four hundred fifty five patients (227 M) were included in the study, of whom 239 with pneumonia (138 M, mean age 80 ± 13) and 216 without pneumonia (89 M, mean age 80 ± 14). After adjustment for age and sex, median levels of hs-CRP were significantly higher in patients with pneumonia (116 mg/L, IQR 46.5–179.0, vs 22.5 mg/dl, IQR 6.9–84.4, p < 0.0001), while procalcitonin median levels were not (0.22 ng/ml IQR 0.12–0.87, vs 0.15 ng/ml, IQR 0.10–0.35, p = 0.08). The ROC analysis showed that, unlike procalcitonin, hs-CRP values were predictive of pneumonia (AUC 0.76, 95 % CI 0.72–0.79, p < 0.0001, cut-off value 61 mg/L), even after adjustment for possible confounders including nursing home residence and dementia. Serum hs-CRP levels >61 mg/L were independently associated with a 3.59-fold increased risk of pneumonia (OR 3.59, 95 % CI 2.35–5.48, p < 0.0001). In elderly multimorbid patients who require hospital admission for respiratory symptoms, serum hs-CRP testing seems to be more useful than procalcitonin for guiding the diagnostic process when clinical suspicion of pneumonia is present. Procalcitonin testing might hence be not recommended in this setting.